VEUS is a fully automated diagnostic system for rapid detection of traumatic brain injury using blood-based biomarkers GFAP and UCH-L1. The platform employs magnetic particle immunoassay technology to deliver results within 15-50 minutes with high sensitivity and accuracy.
Manufactured by
South Korea
VEUS, the abbreviation of Versatile, Easy, and User-friendly System, is a diagnostic system: Versatile – almost all in vitro diagnostic items are applicable; Easy – the system entirely automated enabling easy testing with no pretreatment required; User-friendly – anybody can use the system easily. Furthermore, it delivers rapid and accurate results for efficient clinical decision-making.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
ABCDx
Spain · 3 relevant products
Rapid Technology LLC
Russia · 2 relevant products
Lansion Biotechnology Co., Ltd.
China · 1 relevant product
Shandong Kanghua Biotechnology Co.,Ltd.
China · 1 relevant product
INTA S.r.l.
Italy · 1 relevant product
Quidel China Ltd.
China · 1 relevant product
Abbott
United States · 2 relevant products
Pockit Diagnostics Ltd - Upfront diagnostics
United Kingdom · 2 relevant products
IDL Diagnostics AB
Sweden · 1 relevant product
Beijing Jianping Jinxing Biomedical Co., Ltd
China · 1 relevant product
1 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 16 closest product alternatives
ABCDx · Spain
A point-of-care diagnostic solution powered by advanced blood-based biomarkers for brain injuries. LVOCheck is designed for the selection and triage of large vessel occlusion (LVO) stroke patients to identify those requiring rapid treatment. The platform utilizes proprietary Software as a Medical Device technology to differentiate between ischemic and haemorrhagic stroke and detect mild traumatic brain injury.
Rapid Technology LLC · Russia
Point-of-care diagnostic test for detecting ischemic stroke and traumatic brain injury based on biomarkers.
Lansion Biotechnology Co., Ltd. · China
In vitro diagnostic reagent for neurological injury assessment. Supports rapid detection of brain injury biomarkers.
Rapid Technology LLC · Russia
Rapid diagnostic test for assessment of traumatic brain injury using key biomarkers.
Shandong Kanghua Biotechnology Co.,Ltd. · China
Vascular Endothelial Growth Factor (VEGF) is a biomarker assay for clinical diagnostics used in immunodiagnostic platforms. It detects and quantifies VEGF levels in patient samples to support diagnosis and monitoring of angiogenesis-related conditions including oncology, cardiovascular disease, and inflammatory disorders. The assay integrates with automated diagnostic analyzers for rapid, reproducible results in clinical laboratory settings.
INTA S.r.l. · Italy
A specialized diagnostic test detecting up to six traumatic brain injury biomarkers from a single drop of blood using the NanoAnalyzer platform. Results are displayed within minutes via AI-powered analysis, enabling rapid clinical decision-making in emergency settings.
ABCDx · Spain
A point-of-care diagnostic test that detects mild traumatic brain injury using a drop of blood from a finger prick. TBICheck identifies a combination of biomarkers to detect brain lesions and can rapidly discharge patients with suspected brain injury within 15 minutes, avoiding the need for CT-scan in approximately half of traumatic brain injury patients with no brain injury.
ABCDx · Spain
Rapid diagnostic test for detecting large vessel occlusion in acute ischemic stroke patients using brain biomarkers. Enables fast clinical validation and patient stratification to guide immediate intervention decisions in stroke management.
Quidel China Ltd. · China
Point-of-care rapid diagnostic tests delivering accurate results within minutes. Enables faster diagnoses and better-informed clinical treatment decisions across multiple disease areas.
Abbott · United States
Mild traumatic brain injury biomarker diagnostic test designed to improve emergency department care and clinical decision-making through rapid, accurate diagnosis.
Pockit Diagnostics Ltd - Upfront diagnostics · United Kingdom
LVOne is a rapid diagnostic test for detecting Large Vessel Occlusion (LVO) stroke using a novel combination of D-dimer and GFAP biomarkers. Portable and stable at room temperature, it delivers results in minutes without additional equipment, enabling faster clinical decision-making in ambulances and urgent care settings. Validated across 500+ patients in NHS stroke hospitals.
IDL Diagnostics AB · Sweden
A point-of-care test for primary diagnosis and monitoring of bladder cancer. The test provides non-invasive detection with high accuracy for clinical management of bladder cancer patients.
4 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products